Effectiveness of three interventions on primary care physicians' medication prescribing in Riyadh city, Saudi Arabia;Efficacité de trois interventions sur le comportement prescripteur des médecins en soins de santé primaires à Riyadh (Arabie Saoudite)

Eastern Mediterranean Health Journal

Volumn 17, Issue 2, 2011, Pages 172-179

  Qureshi, N A ^a   Neyaz, Y ^a   Khoja, T ^b   Magzoub, M A ^c   Haycox, A ^c   Walley, T ^c  

^a MINISTRY OF HEALTH   (Saudi Arabia)

^b Ministry of Health ^*

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; EDUCATION PROGRAM; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; MEDICAL EDUCATION; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIMARY HEALTH CARE; PUBLIC HEALTH SERVICE; QUESTIONNAIRE; SAUDI ARABIA; SELF REPORT;

EID: 79952139035     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2011.17.2.172     Document Type: Article

References (33)

1. Neyaz Y et al. Medication prescribing pattern in primary care in Riyadh city, Saudi Arabia. Eastern Mediterranean Health Journal, 2011,17(2):149-155.
2. Khoja T et al. Medication errors in primary care in Riyadh city, Saudi Arabia. Eastern Mediterranean Health Journal, 2011,17(2):156-159.
3. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database of Systematic Reviews, 2005, 4:CD003539.
4. Walley T, Mossialos E. Financial incentives and prescribing. In: Mossialos E, Mrazek M, Walley T, eds. Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality. Milton Keynes, UK, Open University Press, 2004.
5. Bligh J, Walley T. The UK indicative prescribing scheme: background and operation. PharmacoEconomics, 1992, 2:137-152.
6. Mitchell P. US urged to fight "Unacceptable" rate of medication errors. Lancet, 1999, 354:16.
7. Schubert K et al. Development of indicators for assessing the quality of prescribing of lipid-lowering drugs: data from the pharmacotherapeutic quality circles in Hesse, Germany. International Journal of Clinical Pharmacology and Therapeutics, 2001, 39:492-498.
8. Krobot KJ et al. The disparity in access to new medication by type of health insurance: lessons from Germany. Medical Care, 2004, 42:487-491.
9. Puig-Junoy J. Incentives and pharmaceutical reimbursement reforms in Spain. Health Policy, 2004, 67:149-165.
10. Cheng T. The impact of welfare reforms, health, and insurance status on welfare recipients' health care access. Journal of Health Care for the Poor and Underserved, 2005, 16:588-599.
11. O'Brien MA et al. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews, Issue 3, 2006.
12. Harris CM et al. Prescribing-a case for prolonged treatment. Journal of the Royal College of General Practitioners, 1985, 35:284-287.
13. Chapman S, Durieux P, Walley T. Good prescribing practice. In: Mossialos E, Mrazek M, Walley T, eds. Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality. Milton Keynes, UK, Open University Press, 2004.
14. De Vries T PGM et al. Guide to good prescribing: a practical manual. Geneva, World Health Organization, 1994 (WHO/ DAP/94.11).
15. Neville RG et al. A classification of prescription errors. Journal of the Royal College of General Practitioners, 1989, 39:110-112.
16. François P et al. Evaluation of a program to improve the prescription-writing quality in hospital. International Journal of Health Care Quality Assurance Incorporating Leadership in Health Services, 2001, 14:268-274.
17. Davis RS et al. Changing physician prescribing patterns through problem-based learning: an interactive, teleconference casebased education program and review of problem-based learning. Annals of Allergy, Asthma and Immunology, 2004, 93:237-242.
18. Khoja TA, Al-Ansary LA. Asthma in Saudi Arabia: is the system appropriate for optimal primary care? Journal of Public Health Management and Practice, 1998, 4:64-72.
19. Dormuth CR et al. Effect of periodic letters on evidence-based drug therapy on prescribing behaviour: a randomized trial. Canadian Medical Association Journal, 2004, 171:1057-1061.
20. Madridejos-Mora R, Amado-Guirado E, Pérez-Rodríguez MT. Effectiveness of the combination of feedback and educational recommendations for improving drug prescription in general practice. Medical Care, 2004, 42:643-648.
21. Bantar C et al. Alternative indicators for monitoring the quality of a continuous intervention program on antibiotic prescribing during changing healthcare conditions. Journal of Chemotherapy (Florence, Italy), 2005, 17:277-282.
22. Belongia EA et al. Impact of statewide program to promote appropriate antimicrobial drug use. Emerging Infectious Diseases, 2005, 11:912-920.
23. Rausell Rausell VJ et al. Efectividad de una intervencion en la mejora de la calidad de prescripcion con receta medica en atencion especializada [Effectiveness of an intervention to improve medical prescription quality in specialized care]. Farmacia Hospitalaria, 2005, 29:86-94.
24. Herbert CP et al. Better Prescribing Project: a randomized controlled trial of the impact of case-based educational modules and personal prescribing feedback on prescribing for hypertension in primary care. Family Practice, 2004, 21:575-581.
25. Mihill C, Kirkness B. Hard rations: Getting the right treatment for the NHS. London, Association of the British Pharmaceutical Industry, 1999.
26. Walley T, Mrazek M, Mossialos E. Regulating pharmaceutical markets: improving efficiency and controlling costs in the UK. International Journal of Health Planning and Management, 2005, 20:375-398.
27. Mikuls TR et al. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology, 2005, 44:1038-1042.
28. Petrova GI. Monitoring of national drug policies-regional comparison between Bulgaria, Romania, Macedonia, Bosnia Herzegovina. Central European Journal of Public Health, 2001, 9:205-213.
29. Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value in Health, 2004, 7:204-215.
30. Marinker M, Reilly P. Rational prescribing: How can it be judged? Controversies in health care policies: challenges to practice. London, British Medical Journal Publishing Group, 1994:89-110.
31. Øvretveit J. A comparison of approaches to health service quality in the UK, USA, and Sweden and of the use of organizational audit frameworks. European Journal of Public Health, 1994, 4:46-54.
32. Wagner C, DeBakker DH, Groenewegen PP. A measuring instrument for evaluation of quality systems. International Journal for Quality in Health Care, 1999, 11:119-130.
33. Azeem Majeed A, Evans N, Head P. What can PACT tell us about prescribing in general practice? British Medical Journal, 1997, 315:1515.